The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines helped control the spread of the virus, the emergence of new variants continues ...

Engineered M13 phage-based biosensor offers rapid, label-free detection of SARS-CoV-2 spike protein, demonstrating femtogram-level sensitivity in tests.

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ — Javelin Sciences, a pioneering certified biotechnology laboratory specializing in advanced ...

As we approach the five-year anniversary of the COVID-19 pandemic, it is worth reflecting not only on the paradigm-shifting impact of the initial outbreak, but also on how SARS-CoV-2 continues to ...

A review published in Infection highlights viral mimic systems that safely replicate key features of pathogens like SARS-CoV-2. These technologies allow vaccine testing in lower-level biosafety ...

SARS-CoV-2 triggers the production of the antiviral protein IFN- γ , which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN- y production ...

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation ...

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every once in a while, we stumble upon something unexpected—something that ...